KRAS G12C inhibitors
US11267812B2 · kind B2 · utility
5Cited by
6References
34Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 17, 2017 |
| Grant date | Mar 8, 2022 |
| Priority date | — |
| Expiry date | Apr 17, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.